Vabysmo 6 MG/0.05 ML vial 0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFBM5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,884
Award facts
- Contract value 100% obligated
- $14,883.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,883.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 ml vials. The delivery order was issued on November 24, 2025, with an ultimate completion date of December 16, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order represents one of numerous pharmaceutical supply agreements issued to DMS Pharmaceutical Group by the DLA's Medical Supply Chain division to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and a performance period extending through December 31, 2036. The PPV-G GEN V represents a significant component of the DLA's $30.3 billion pharmaceutical acquisition strategy, establishing multiple regional prime vendor contractors to supply branded and generic prescription medications, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a prime vendor contractor demonstrates its competitive capability and established performance in providing specialized pharmaceutical products to support the federal military medical system globally.
Quick answers
Who was awarded contract SPE2DR26FFBM5?
SPE2DR26FFBM5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FFBM5 worth?
The government has obligated $14,884 on SPE2DR26FFBM5.
Is contract SPE2DR26FFBM5 an order under another contract?
Yes. SPE2DR26FFBM5 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBM5 competed?
The extent of competition for SPE2DR26FFBM5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award